As legalization approaches cannabis companies must compete for supply agreements and retail space…[and those companies best] increasing their production and sales to meet demand could capture a strong retail presence early on. The Canadian cannabis stocks on our list today have released their financial results recently, giving investors insight into their production and revenue increases.
The original article has been edited here for length (…) and clarity ([ ])
1. Cronos Group Inc. (TSXV:CRON)
Cronos Group is a licensed producer of medical marijuana…producing marijuana primarily out of its Peace Naturals facilities, which have a production capacity of 6,650 kg/year, with construction of a 286,000 sq. ft. facility with a production capacity of 33,500 kg/year expected to be completed by the summer of 2018. Cronos holds four joint ventures for distribution of the MedMen brand in Canadian retail stores, products for indigenous communities, and production facilities in Australia and Israel.
- Market Cap: $1,333.9 Million
- Last EPS Report Date: 5/15/2018
- Grams Sold, Q/Q: N/A
- Grams Sold, Y/Y: 672.0%
- Revenue, Q/Q: 82.9%
- Revenue, Y/Y: 473.2%
- Return since Report Date: -8.4%
2. CannTrust Holdings Inc. (TSX:TRST)
CannTrust is a Canada-based licensed producer of medical cannabis…selling its products…online and delivered to registered patients. CannTrust’s original 50,000 square foot production facility located in Vaughan, Ontario uses hydroponic technology to produce at an annual capacity of 3,600 KG. Furthermore, CannTrust has set aside a 46-acre property, where it plans to add capacity with a 430,000-square foot expansion.
- Market Cap: $810.5 Million
- Last EPS Report Date: 5/15/2018
- Grams Sold, Q/Q: 29.6%
- Grams Sold, Y/Y: 195.4%
- Revenue, Q/Q: 13.7%
- Revenue, Y/Y: 233.2%
- Return since Report Date: -15.4%
3. Aurora Cannabis Inc. (TSX:ACB)
Aurora Cannabis is a licensed producer and seller of medical marijuana and cannabis oil…and operates three production facilities with a total capacity of 15,800kg. Currently, the Company is engaged in the construction of its new 800,000 sq. ft. production facility in Alberta, called Aurora Sky. On May 14, Aurora announced the acquisition of MedReleaf (TSX:LEAF) for $3.2B in stock.
- Market Cap: $4,045.6 Million
- Last EPS Report Date: 5/8/2018
- Grams Sold, Q/Q: 16.5%
- Grams Sold, Y/Y: 107.2%
- Revenue, Q/Q: 37.6%
- Revenue, Y/Y: 211.1%
- Return since Report Date: -11.2%
4. Organigram Holdings Inc. (TSXV:OGI)
Organigram is a Canada-based marijuana producer operating in New Brunswick…producing 22,000 kg/year out of its 134,000 sq. ft. facility. OGI plans to expand this facility, increasing production to 65,500 kg by April 2019 and 113,000 kg by April 2020. The Company has signed Memorandums of Understanding with New Brunswick and Prince Edward Island to supply cannabis to the recreational market.
- Market Cap: $579.5 Million
- Last EPS Report Date: 4/24/2018
- Grams Sold, Q/Q: 21.8%
- Grams Sold, Y/Y: 67.8%
- Revenue, Q/Q: 14.6%
- Revenue, Y/Y: 155.2%
- Return since Report Date: 16.0%
5. Aphria Inc. (TSX:APH)
Aphria is a licensed producer and supplier of medical marijuana…with a greenhouse production facility is located on a 169-acre property in Leamington, Ontario. The Company currently produces 9,000kg and plans to expand its production facility to add an additional 90,000kg.
- Market Cap: $2,497.0 Million
- Last EPS Report Date: 4/16/2018
- Grams Sold, Q/Q: 15.4%
- Grams Sold, Y/Y: 118.8%
- Revenue, Q/Q: 20.7%
- Revenue, Y/Y: 100.6%
- Return since Report Date: 4.3%
Related Articles From the munKNEE Vault:
Today we have identified seven Canadian cannabis producers based on sale cost and production efficiency.
To take advantage of another potential upswing in the market, we have selected 5 cannabis companies, which analysts believe are undervalued. The Canadian marijuana stocks on our list today currently have 100% upside on average according to analysts, indicating that these stocks could post strong returns in the near-term.
As recreational legalization of marijuana in Canada approaches this summer, these companies have plans to meet the upcoming demand. If marijuana continues its rally, the Canadian marijuana stocks on our list could see strong returns in both the short and long term.
The top spot in the Canadian cannabis industry belongs to Canopy Growth Corp. but some competitors, such as Aurora Cannabis Inc., have the scope, scale, and differentiation to take on the market leader. Of these two which stock is more attractive?
Today we will be comparing the current and future prospects of Aurora Cannabis and Aphria Inc. – the only two companies with the scope, scale, and differentiation to take on Canopy Growth.
Due to the early stages of the cannabis industry and its growth prospects, investors have not expected cannabis companies to generate positive earnings. Instead they have valued the stocks primarily on hope for a lucrative future. That being said, however, we have identified 4 Canadian cannabis stocks that are expected to generate positive earnings in the next 12 months. If they live up to their earnings expectations, it could begin a time when investors look for companies with sustainable growth prospects, as opposed to those that are expected to have the highest short-term revenue growth.
Like technology, the battery metals and cannabis sectors have upside attached to secular trends that are changing our world. As a result, all of these sectors are poised to continue expanding at rapid rates.
Being able to sell products at a high margin is a good sign of efficiency. Doing so leaves more cash to dedicate to other expenses and service debt obligations. Identifying undervalued companies with strong gross margins in the young marijuana industry is important, given the upcoming Canadian legalization of marijuana for recreational purposes in 2018. Today we have identified 4 Canadian marijuana stocks that have underperformed their peers despite healthy gross margins.
Investing in marijuana-related stocks is a high-risk, high-reward game due to all the uncertainties surrounding the legalization of the drug. Companies that do succeed, however, have potential to bring large capital gains. That being said we have identified five Canadian marijuana stocks with the biggest upside potential, according to consensus analyst price targets.
Identifying companies with high gross margins in the young marijuana industry is important because operating costs are likely to decrease as the industry matures, leaving these companies with high earnings potential. Today we have identified five Canadian marijuana stocks with gross margins well above their industry peers.
The search is now on for the next junior marijuana stock that is ripe for acquisition. Will it be one of the 5 we’ve identified based upon their high revenue growth profiles?
Today’s infographic comes to us from Evolve ETFs, and it shows what investors should know as the legal cannabis sector comes out of the dark.
As recreational legalization in Canada approaches this summer, the 4 marijuana stocks on our list today have plans to meet the upcoming demand. If the marijuana sector continues its rally, these stocks…are expected to generate significant EBITDA growth over the coming year.